We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$16.8B
AUM Growth
+$2.43B
(+17%)
Cap. Flow
+$2.2B
Cap. Flow
% of AUM
13.07%
Top 10 Holdings %
Top 10 Hldgs %
12.03%
Holding
1,764
New
564
Increased
341
Reduced
326
Closed
526
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.58% |
| 3 | Consumer Staples | 7.89% |
| 4 | Financials | 7.87% |
| 5 | Healthcare | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODP
851
DELISTED
ODP
ODP
| $600K | ﹤0.01% |
8,455
+3,445
| +69% | +$186K |
|
852
Fluor
FLR
$7.96B
| $598K | ﹤0.01% |
+11,132
| New | +$523K |
|
853
Tractor Supply
TSCO
$18B
| $595K | ﹤0.01% |
32,900
+18,250
| +125% | +$312K |
|
854
Helix Energy Solutions
HLX
$1.41B
| $591K | ﹤0.01% |
+105,490
| New | +$445K |
|
855
Freeport-McMoran
FCX
$97.5B
| $590K | ﹤0.01% |
57,100
-1,091,194
| -95% | -$7.67M |
|
856
HP
HPQ
$27.5B
| $585K | ﹤0.01% |
47,500
+29,510
| +164% | +$316K |
|
857
Aon
AON
$76B
| $577K | ﹤0.01% |
+5,522
| New | +$517K |
|
858
Nasdaq
NDAQ
$52.9B
| $572K | ﹤0.01% |
25,860
-524,727
| -95% | -$10.8M |
|
|
PX
859
DELISTED
Praxair Inc
PX
| $572K | ﹤0.01% |
+5,000
| New | +$522K |
|
860
Microchip Technology
MCHP
$46B
| $569K | ﹤0.01% |
23,600
-1,022,988
| -98% | -$22.8M |
|
861
TransDigm Group
TDG
$67.7B
| $568K | ﹤0.01% |
+2,580
| New | +$563K |
|
862
Ametek
AME
$58.2B
| $564K | ﹤0.01% |
+11,275
| New | +$537K |
|
863
Semtech
SMTC
$13B
| $562K | ﹤0.01% |
25,570
-55,020
| -68% | -$1.06M |
|
864
Bankunited
BKU
$3.36B
| $561K | ﹤0.01% |
16,303
-243,805
| -94% | -$8.16M |
|
865
Trex
TREX
$5.01B
| $559K | ﹤0.01% |
46,688
+4,344
| +10% | +$42.3K |
|
866
Kennametal
KMT
$2.52B
| $556K | ﹤0.01% |
+24,727
| New | +$480K |
|
|
TECD
867
DELISTED
Tech Data Corp
TECD
| $555K | ﹤0.01% |
7,230
-280
| -4% | -$19.2K |
|
868
Accenture
ACN
$108B
| $552K | ﹤0.01% |
4,785
-117,817
| -96% | -$12.1M |
|
|
869
C.H. Robinson
CHRW
$17.5B
| $550K | ﹤0.01% |
7,409
-1,950,063
| -100% | -$134M |
|
|
ESRX
870
DELISTED
Express Scripts Holding Company
ESRX
| $549K | ﹤0.01% |
7,995
+3,440
| +76% | +$247K |
|
871
Tetra Tech
TTEK
$9.07B
| $548K | ﹤0.01% |
+91,955
| New | +$489K |
|
872
Matsons
MATX
$6.18B
| $547K | ﹤0.01% |
+13,628
| New | +$534K |
|
873
AbbVie
ABBV
$435B
| $546K | ﹤0.01% |
9,560
-1,317,944
| -99% | -$73.5M |
|
|
WFM
874
DELISTED
Whole Foods Market Inc
WFM
| $544K | ﹤0.01% |
17,500
-491,604
| -97% | -$15.4M |
|
875
Citizens Financial Group
CFG
$30.6B
| $541K | ﹤0.01% |
25,845
-2,543,483
| -99% | -$53.9M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Balyasny Asset Management held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Balyasny Asset Management deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Balyasny Asset Management's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Balyasny Asset Management added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Balyasny Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Balyasny Asset Management fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Balyasny Asset Management's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Balyasny Asset Management opened 564 new positions and closed 526 in Q1 2016.
- Balyasny Asset Management's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.